Venture Leaders Biotech 2025 kick off at Swiss Biotech Day ahead of Boston roadshow

Abrinca GmbH: Abrinca has built the engine for microbial innovation.

A major barrier to discovery in microbial genomics research is data analysis, which demands time-intensive collaboration between microbiologists and bioinformaticians. Abrinca eliminates this hurdle w... Read more

Amporin Pharmaceuticals AG: Acute membrane repair for deadly degenerative diseases.

Amporin Pharmaceuticals AG is developing a breakthrough new class of small molecule amyloid pore inhibitors that can uniquely protect and repair cell and mitochondrial membranes from the damage caused... Read more

Apricot Therapeutics AG: Data-driven drug discovery for targeted medicine

Apricot BIO, a spin-off from the University of Zürich, is positioning itself to become the “Google maps” of the tumor cell by combining drug perturbations, image-based phenotypic profiling, systems bi... Read more

Aukera Therapeutics GmbH: Our drugs keep the cell's growth engine mTORC1 in check

Aukera Therapeutics is a preclinical-stage biotech spin-off from the University of Basel, emerged from pioneering research on mTOR biology. We specialize in leveraging protein design to drive drug dis... Read more

ENANTIOS AG: Solution to analyze chiral molecules and biologics.

Modern pharmaceutics are becoming more and more structurally complex, and traditional measurement techniques are slowing down the discovery pipeline. At Enantios we are leveraging new measurement tech... Read more

Encelta AG: Providing healthy immune cells to patients in need.

Encelta has developed a groundbreaking cell therapy platform addressing key challenges in the field. Our allogeneic T-cell product is uniquely compatible with all 7 approved bispecific antibodies and ... Read more

HemostOD SA: Producer of donor free universal platelets for transfusion

HemostOD is assembling a novel, cell-based production platform based on natural human biology that makes blood platelets for transfusion in hours, not the days taken by its competitors. In pre-clinic... Read more

InkVivo Technologies SA: Best in class polymer platform for formulating drug delivery

InkVivo integrates its proprietary polymer platform with AI predictive modeling to accelerate drug formulation and de-risk clinical outcomes. This combined materials-science and data-driven approach i... Read more

Juvion Health Sciences SA: Improving health span in the elderly: Nurturing motion

Juvion’s vision is to redefine aging biology. We aim to prove that age-related loss of movement and memory is driven by weakening cell communication in the nervous system, and that it can be restored ... Read more

Nerai Bioscience AG: Reimagining genetic medicine through protein engineering.

Nerai pioneers novel highly personalized CRISPR proteins to deliver lifelong cures for diseases beyond the reach of current genome editing. By fusing AI with programmable biology, its editors redefine... Read more